Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

4D Heart-on-a-chip: Modeling circadian rhythms in the human heart to study cardiac (patho)physiology and advance therapy

Objetivo

Cardiovascular disease is the leading cause of death worldwide. Growing evidence shows that circadian rhythms profoundly shape cardiac health, governing the timing and severity of cardiac events, influencing drug efficacy, and, when chronically disrupted (e.g. in shift work, sleep disorders, or jet lag), markedly increasing disease risk. Yet, the mechanisms by which they regulate the human heart remain unknown, as current knowledge relies largely on animal models with limited translational relevance. Predictive human heart models capable of capturing circadian rhythms and their regulation would be transformative for cardiac research and precision medicine. Building on my expertise in engineered cardiac tissues and organs-on-chip (OOC), I propose to develop a pioneering 4D heart-on-a-chip that models, monitors, and manipulates circadian rhythms, in a physiologically relevant model of the human heart (Aim 1). This platform will integrate tissues composed of reporter cell lines for real-time tracking of intrinsic circadian rhythmicity in tissues linked to an OOC system delivering oscillating hormones and metabolites that simulate light-dark and feeding-fasting cycles. These cues will be applied through an automated feedback-loop system, either in synchrony or in deliberate misalignment with the tissue’s intrinsic rhythms, to enable modeling of both homeostatic and disrupted conditions. Using this unique approach, I propose to address two fundamental questions at the intersection of cardiac biology and chronobiology: (i) how the time-of-day modulates cardiac sensitivity to injury (Aim 2), and (ii) how circadian misalignment leads to cardiac disease (Aim 3). Beyond mechanistic studies, the 4D platform will provide an unprecedented testbed for developing circadian-guided therapies. Successful completion of this work will help reduce the global burden of heart disease and transform the prediction, prevention, and treatment of time-sensitive cardiovascular pathologies.

Ámbito científico (EuroSciVoc)

Palabras clave

Programa(s)

Tema(s)

Régimen de financiación

HORIZON-ERC - HORIZON ERC Grants

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) ERC-2026-STG

Ver todos los proyectos financiados en el marco de esta convocatoria

Institución de acogida

TEL AVIV UNIVERSITY
Aportación neta de la UEn
€ 2 880 000,00
Coste total
€ 2 880 000,00

Beneficiarios (1)